{
  "num_tested_probands": [
    [
      1
    ],
    [
      8
    ],
    [
      2
    ],
    [
      7
    ],
    [
      9
    ],
    [
      11
    ],
    [
      15
    ]
  ],
  "num_positive_het_probands": [
    [
      0
    ],
    [
      0
    ],
    [
      0
    ],
    [
      3
    ],
    [
      0
    ],
    [
      0
    ],
    [
      0
    ]
  ],
  "positive_phenotypes": [
    [
      "moderate ID",
      "microcephaly",
      "ataxia",
      "speech impairment",
      "aggressive behavior"
    ],
    [
      "SARS",
      "WARS2"
    ],
    [
      "adult-onset leukoencephalopathy with axonal spheroids and pigmented glia"
    ],
    [
      "Impaired serine-activation of the SARS p.Asp172Asn enzyme",
      "Impaired mitochondrial localization of the WARS2 p.Trp13Gly protein"
    ],
    [
      "Moderate ID",
      "Speech impairment",
      "Seizures",
      "Ataxia",
      "Muscular weakness"
    ],
    [
      "Charcot-Marie-Tooth disease type 2N (CMT2N)",
      "Autosomal recessive intellectual disability",
      "Alpers syndrome",
      "Peripheral neuropathy",
      "Leigh syndrome",
      "GABAergic neuron loss in the hippocampus and cerebral cortex",
      "Autism spectrum disorders"
    ]
  ],
  "num_compound_or_double_hets": [
    [
      2
    ],
    [
      0
    ],
    [
      0
    ],
    [
      0
    ],
    [
      1
    ],
    [
      1
    ],
    [
      0
    ],
    [
      0
    ]
  ],
  "explanation": {
    "num_tested_probands": [
      [
        "The study reports on two Iranian families affected by autosomal recessive intellectual disability (ARID). The proband in the first family was homozygous for a missense mutation in the SARS gene, while the second family had a compound heterozygous genotype of the WARS2 gene."
      ],
      [
        "The number of probands tested is 8, as indicated in the table."
      ],
      [
        "The number of probands tested is 7, as stated in the figure legend."
      ],
      [
        "The study tested 9 probands."
      ],
      [
        "The number of probands tested is 11, as stated in Figure 3."
      ],
      [
        "The study reports on 15 probands who underwent genetic testing."
      ]
    ],
    "num_positive_het_probands": [
      [
        "No probands were reported to be heterozygous for a pathogenic variant."
      ],
      [
        "No proband was found to be heterozygous for a pathogenic variant."
      ],
      [
        "Three probands were heterozygous for a pathogenic variant, as indicated by the linkage analysis and mutation analysis sections."
      ],
      [
        "No proband was heterozygous for a pathogenic variant."
      ],
      [
        "No proband was found to be heterozygous for a pathogenic variant."
      ],
      [
        "No heterozygous probands were identified with pathogenic variants."
      ]
    ],
    "positive_phenotypes": [
      [
        "The study reports on several phenotypes associated with the mutations, including moderate ID, microcephaly, ataxia, speech impairment, and aggressive behavior."
      ],
      [
        "The positive phenotypes associated with the probands are SARS and WARS2."
      ],
      [
        "The clinical phenotype associated with the positive probands is adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as described in the table 1 section."
      ],
      [
        "Positive phenotypes include impaired serine-activation of the SARS p.Asp172Asn enzyme and impaired mitochondrial localization of the WARS2 p.Trp13Gly protein."
      ],
      [
        "The positive proband phenotypes include moderate ID, speech impairment, seizures, ataxia, and muscular weakness, as described in the DISCUSSION section."
      ],
      [
        "Multiple clinical phenotypes are associated with positive probands, including Charcot-Marie-Tooth disease type 2N (CMT2N), autosomal recessive intellectual disability, Alpers syndrome, peripheral neuropathy, Leigh syndrome, GABAergic neuron loss in the hippocampus and cerebral cortex, and autism spectrum disorders."
      ]
    ],
    "num_compound_or_double_hets": [
      [
        "Two probands were reported to have compound or double heterozygous mutations."
      ],
      [
        "There were no compound or double heterozygotes reported in this study."
      ],
      [
        "No compound or double heterozygotes were reported in this study."
      ],
      [
        "One proband was reported to be a compound or double heterozygote."
      ],
      [
        "One compound or double heterozygous genotype was found in affected individuals, consisting of a deleterious frame-shift mutation and a missense change (p.Trp13Gly) in the mitochondrial tryptophanyl-tRNA synthetase encoding WARS2."
      ],
      [
        "No compound or double heterozygous mutations were reported."
      ]
    ],
    "Clinical_report_of_family_1": [
      [
        {
          "Family_history": "The family has a history of intellectual disability (ID) in four out of nine children.",
          "Pedigree": "Figure 1A",
          "Affected_children": "Four affected children with ID, microcephaly, ataxia, and muscular weakness.",
          "Clinical_description": "Moderate ID, speech impairment, aggressive behavior, microcephaly, ataxia, and muscular weakness.",
          "Genetic_test": "DNA extracted from peripheral blood of patients (III:4, III:9, III:10, III:11), three healthy siblings, and their parents."
        }
      ]
    ],
    "Clinical_report_of_family_2": [
      [
        {
          "Family_history": "The family has a history of intellectual disability (ID) in three out of nine children.",
          "Pedigree": "Figure 1B",
          "Affected_children": "Three affected children with ID, athetosis, aggressive behavior, and speech impairment.",
          "Clinical_description": "Moderate ID, athetosis, aggressive behavior, and speech impairment.",
          "Genetic_test": "DNA extracted from peripheral blood of patients (V:6, V:7, V:8), their parents."
        }
      ]
    ],
    "compound_or_doubles": [
      []
    ]
  },
  "quote_snippets": [
    [
      "The variant affects an amino acid residue that is highly conserved across the animal kingdom and it leads to unstable protein expression in mammalian cells.",
      "The frameshift mutation on the paternal allele (c.325delA, p.Ser109Alafs*159) very likely leads to the degradation of WARS2 mRNA by NMD, given its position relative to the terminal exon.",
      "The second change (c.37T>G, p.Trp13Gly), on the maternal allele, affects a mitochondrial signal peptide (SP) leading to mislocalization of the mutant protein in the cells."
    ],
    [
      "mutations in AARS2 in a series of CSF1R-negative patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.",
      "consanguinity",
      "First cousins"
    ],
    [
      "mutations in AARS2 in a series of CSF1R-negative patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.",
      "The protein domain structure shown is based on UniProtKB/Swiss-Prot entry P49591.",
      "The positions of the missense mutation c.37T>G in exon one and the deletion c.325delA in exon two of WARS2 as well as the positions of the corresponding protein changes p.Trp14Gly and p.Ser109Alafs*15 are indicated."
    ],
    [
      "The puri\ufb01ed GST protein was used as an additional control (data not shown).",
      "This is important as p.Trp13Gly is located within the mitochondrial transit peptide. This peptide forms a special signal that is required to \ufb01nd the correct location of the protein in the cell.",
      "To experimentally test the hypothesis that the p.Trp13Gly change is functionally relevant, we \ufb01rst performed immuno\ufb02uorescence microscopy experiments, which revealed that WARS2-EYFP and p.Trp13Gly-WARS2-EYFP were present in the cytoplasm of COS7 cells, in dot-like structures.",
      "Furthermore, its accumulation is dependent upon mitochondrial membrane potential (Chazotte, 2011). Upon treatment, most WARS2-WT-positive granules overlapped with the mitochondria staining, thus con\ufb01rming previous \ufb01ndings (Jorgensen, Sogaard, Rossing, Martensen, & Justesen, 2000), whereas a partial reduction in the overlapping signal was observed for the p.Trp13Gly mutant (Fig. 3A).",
      "Interestingly, by immuno\ufb02uorescence analysis, using a speci\ufb01c antibody against SDHA, a catalytic subunit of succinate-ubiquinone oxidoreductase, and part of the mitochondrial respiratory chain, we observed a marked decrease of SDHA signal (Supp. Fig. S8) in cells overexpressing WT WARS2 compared with cells overexpressing the mutant protein and control cells."
    ],
    [
      "ThegreensignalcorrespondstoWARS2staining,theredsignalcorrespondtoMitoTracker,a\ufb02uorescentdyethatstains mitochondria whereas the blue corresponds to nuclear DAPI staining.",
      "We could show that the p.Asp172Asn alteration we identi\ufb01ed leads to impaired serine-activation of the SARS enzyme.",
      "The latter has a putative effect on structure and function of the gene product from the remaining allele and demon-strate impaired mitochondrial localization of the remaining WARS2 p.Trp13Gly protein.",
      "This might in itself have only a subliminal effect, which when present in a heterozygous state, may not have signi\ufb01cant pathogenic consequences.",
      "Ectopic expression of WT WARS2 in HEK293T cells induced a signi\ufb01cant reduction in the amount of SDHA protein as compared with controls or to cells overexpressing the p.Trp13Gly variant of WARS2.",
      "This might sug-gest a role for this protein in the translation of SDHA, which would then be partially impaired in the mutant protein."
    ],
    [],
    [
      "A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).",
      "Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.",
      "Mutations of the aminoacyl-tRNA-synthetases SARS and WARS2 are implicated in the aetiology of autosomal recessive intellectual disability.",
      "Loss of GABAergic neurons in the hippocampus and cerebral cortex of Engrailed-2 null mutant mice: Implications for autism spectrum disorders.",
      "Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration."
    ]
  ]
}